| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUCUCUUAUUUUUUGCCUUUGCAGAUGAGUUUUGAUCAUCCUGAGAAAA… | 4177 nt | 0.4812 | |
| GAACUUUCUGAUAGCUUAAUAGGAGGAGGUUCCUGUAGGGCGGCACAAC… | 4303 nt | 0.4820 | |
| GCUCUUCUUCCUUCCUUCUCCAGUCCCUUCCACUGUGCGUCUUCUGUCC… | 4604 nt | 0.5002 | |
| GCUCUUCUUCCUUCCUUCUCCAGUCCCUUCCACUGUGCGUCUUCUGUCC… | 3947 nt | 0.4989 |
This gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The protein, which is normally found in the Golgi but can be proteolytically processed to a soluble form, is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CD75, and CD76. This gene has been incorrectly referred to as CD75. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
A study in humans demonstrated that the ST6GAL1 mRNA was significantly upregulated in salivary extracellular vesicles from patients with mild traumatic brain injury (mTBI) compared to controls, and its expression also showed a significant difference between acute emergency department patients and those from an outpatient concussion clinic [Cheng et al. DOI:10.1002/jcp.28139]. A separate study in mice found that the ST6GAL1 gene was upregulated in white blood cells at day 1 post-injury as part of a common cell-to-cell signaling response following both burn injury and trauma-hemorrhage [Lederer et al. DOI:10.1152/physiolgenomics.00086.2007].